Analysts expect market-beating returns from these ASX growth shares

Analysts think these shares could beat the market. But by how much?

| More on:
Man in an office celebrates at he crosses a finish line before his colleagues.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the last 30 years, the Australian share market has delivered a total average return of 9.6% per annum.

While this level of return is excellent, what if we could better that over the next 12 months?

Well, three ASX growth shares that have been tipped to generate market-beating returns are listed below. Here's what you need to know about them:

Lovisa Holdings Ltd (ASX: LOV)

Morgans is tipping big returns from this ASX growth share. It likes the fashion jewellery retailer due to its global expansion plans and the benefits of having an affordable offering in a tough consumer environment. In respect to its expansion plans, the broker notes that Lovisa "plans to enter mainland China in FY24, paving the way for significant longer-term growth."

Morgans has an add rating and a $27.50 price target on its shares. This implies a potential upside of over 38% from current levels.

ResMed Inc. (ASX: RMD)

Another ASX growth share that could have significant upside potential is sleep treatment company ResMed. The team at Citi believes that the recent share price weakness is a buying opportunity for investors.

The broker currently has a buy rating and a $39 price target on its shares. Based on the current ResMed share price of $22.98, this would mean a return of almost 70% over the next 12 months.

TechnologyOne Ltd (ASX: TNE)

A final ASX growth share that has been named as a buy and tipped to generate market-beating returns is enterprise software provider TechnologyOne. Goldman Sachs is a big fan of the company due to its defensive earnings and positive growth outlook. Its analysts "believe that TNE can grow PBT [profit before tax] >15% p.a. across FY23-25E driven by its strong ARR outlook (+18% FY22-25E CAGR) and modest margin expansion (+220bps FY22-25E)".

Goldman Sachs has a buy rating and a $18.30 price target on Technology One's shares. This suggests that its shares could rise 16% over the next 12 months.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Lovisa, ResMed, and Technology One. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Lovisa and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

happy investor, share price rise, increase, up
Growth Shares

2 top ASX growth shares for explosive potential in 2025

These stocks look exciting and compelling to me.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Share Market News

Brokers say these ASX 200 growth stocks could rise 50% to 70%

Analysts think these shares could be dirt cheap and destined to generate big returns.

Read more »

happy investor, share price rise, increase, up
Growth Shares

3 fantastic ASX 200 growth shares to buy in 2025

Analysts have good things to say about these buy-rated shares.

Read more »

Smiling couple looking at a phone at a bargain opportunity.
Growth Shares

The ASX 200 stock with 'a $200 billion gross profit opportunity'

Experts believe this stock has excellent potential.

Read more »

A young girl and boy drinking milk in a garden setting
Growth Shares

2 ASX growth shares set to skyrocket in the next 12 months

These stocks have a lot of potential according to experts.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 no-brainer ASX 200 shares to consider buying with just $1,000

Analysts rate these top stocks very highly. Let's find out why.

Read more »

A happy laughing surfer couple surfing together.
Growth Shares

If I were in my 20s, I'd buy these ASX shares for growth

I think these investments could be great picks for younger Aussies.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Growth Shares

Invest $5,000 into these ASX 200 shares in 2025

Analysts think these shares could be top options for an investment in 2025.

Read more »